Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery N Csaba, M Köping-Höggård, MJ Alonso International journal of pharmaceutics 382 (1-2), 205-214, 2009 | 366 | 2009 |
Nanoparticles for nasal vaccination N Csaba, M Garcia-Fuentes, MJ Alonso Advanced drug delivery reviews 61 (2), 140-157, 2009 | 362 | 2009 |
Colloidal stability of pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms MJ Santander-Ortega, AB Jódar-Reyes, N Csaba, D Bastos-González, ... Journal of colloid and interface science 302 (2), 522-529, 2006 | 251 | 2006 |
Nanotherapies for the treatment of ocular diseases S Reimondez-Troitiño, N Csaba, MJ Alonso, M De La Fuente European Journal of Pharmaceutics and Biopharmaceutics 95, 279-293, 2015 | 187 | 2015 |
PLGA: poloxamer and PLGA: poloxamine blend nanoparticles: new carriers for gene delivery N Csaba, P Caamaño, A Sanchez, F Dominguez, MJ Alonso Biomacromolecules 6 (1), 271-278, 2005 | 181 | 2005 |
PLGA: poloxamer and PLGA: poloxamine blend nanostructures as carriers for nasal gene delivery N Csaba, A Sanchez, MJ Alonso Journal of Controlled Release 113 (2), 164-172, 2006 | 160 | 2006 |
The performance of nanocarriers for transmucosal drug delivery N Csaba, M Garcia-Fuentes, MJ Alonso Expert opinion on drug delivery 3 (4), 463-478, 2006 | 158 | 2006 |
Vaccine delivery carriers: insights and future perspectives JF Correia-Pinto, N Csaba, MJ Alonso International Journal of Pharmaceutics 440 (1), 27-38, 2013 | 148 | 2013 |
Nanoparticles as protein and gene carriers to mucosal surfaces M De La Fuente, N Csaba, M Garcia-Fuentes, MJ Alonso Nanomedicine 3 (6), 845-857, 2008 | 122 | 2008 |
Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response S Fischer, E Schlosser, M Mueller, N Csaba, HP Merkle, M Groettrup, ... Journal of drug targeting 17 (8), 652-661, 2009 | 103 | 2009 |
A comparative study of curcumin-loaded lipid-based nanocarriers in the treatment of inflammatory bowel disease A Beloqui, PB Memvanga, R Coco, S Reimondez-Troitino, M Alhouayek, ... Colloids and Surfaces B: Biointerfaces 143, 327-335, 2016 | 93 | 2016 |
A protective allergy vaccine based on CpG-and protamine-containing PLGA microparticles JMM Gómez, S Fischer, N Csaba, TM Kündig, HP Merkle, B Gander, ... Pharmaceutical research 24, 1927-1935, 2007 | 92 | 2007 |
Ionically crosslinked chitosan nanoparticles as gene delivery systems: effect of PEGylation degree on in vitro and in vivo gene transfer N Csaba, M Köping-Höggård, E Fernandez-Megia, R Novoa-Carballal, ... Journal of biomedical nanotechnology 5 (2), 162-171, 2009 | 86 | 2009 |
Surface coating of PLGA microparticles with protamine enhances their immunological performance through facilitated phagocytosis JMM Gómez, N Csaba, S Fischer, A Sichelstiel, TM Kündig, B Gander, ... Journal of Controlled Release 130 (2), 161-167, 2008 | 85 | 2008 |
Design and characterisation of new nanoparticulate polymer blends for drug delivery N Csaba, L Gonzalez, A Sanchez, MJ Alonso Journal of Biomaterials Science, Polymer Edition 15 (9), 1137-1151, 2004 | 83 | 2004 |
Emerging delivery platforms for mucosal administration of biopharmaceuticals: a critical update on nasal, pulmonary and oral routes LN Thwala, V Préat, NS Csaba Expert opinion on drug delivery 14 (1), 23-36, 2017 | 81 | 2017 |
Polymer-based oral peptide nanomedicines EP Herrero, MJ Alonso, N Csaba Therapeutic delivery 3 (5), 657-668, 2012 | 80 | 2012 |
Polypeptides and polyaminoacids in drug delivery JV González-Aramundiz, MV Lozano, A Sousa-Herves, ... Expert Opinion on Drug Delivery 9 (2), 183-201, 2012 | 68 | 2012 |
Stability and physicochemical characteristics of PLGA, PLGA: poloxamer and PLGA: poloxamine blend nanoparticles: a comparative study MJ Santander-Ortega, N Csaba, MJ Alonso, JL Ortega-Vinuesa, ... Colloids and Surfaces A: Physicochemical and Engineering Aspects 296 (1-3 …, 2007 | 67 | 2007 |
Polyaminoacid nanocapsules for drug delivery to the lymphatic system: Effect of the particle size R Abellan-Pose, C Teijeiro-Valiño, MJ Santander-Ortega, E Borrajo, ... International Journal of Pharmaceutics 509 (1-2), 107-117, 2016 | 64 | 2016 |